Showing results (1-10 of 89) with videos related to
Sort By:
Pageof 9
Current Opinion in Molecular Therapeutics|February 9, 2010
TRU-015, a fusion protein derived from an anti-CD20 antibody, for the treatment of rheumatoid arthritisAndrea Rubbert-RothRheumatology (Oxford, England)|June 22, 2012
Assessing the safety of biologic agents in patients with rheumatoid arthritisAndrea Rubbert-RothNew Biotechnology|April 9, 2011
Recombinant proteins in rheumatology - recent advancesAchim Rothe, Andrea RubbertArthritis Research & Therapy|April 17, 2009
Treatment options in patients with rheumatoid arthritis failing initial TNF inhibitor therapy: a critical reviewAndrea Rubbert-Roth, Axel FinckhZeitschrift Fur Rheumatologie|August 21, 2003
[Interleukin-1 receptor antagonist anakinra (Kineret) for treatment of rheumatic arthritis]Andrea Rubbert-Roth, Andreas PerniokAutoimmunity Reviews|November 1, 2011
To switch or not to switch after a poor response to a TNFα blocker? It is not only a matter of ACR20 OR ACR50Maya H Buch, Andrea Rubbert-Roth, Gianfranco FerraccioliThe Journal of Infectious Diseases|August 4, 2023
Susceptibility to COVID-19 and Immunologic Response to Vaccination in Patients With Immune-Mediated Inflammatory DiseasesAxel Finckh, Adrian Ciurea, Catherine E Raptis, et al.Rheumatology (Oxford, England)|June 22, 2012
Optimizing outcomes in rheumatoid arthritis patients with inadequate responses to disease-modifying anti-rheumatic drugsKarel Pavelka, Arthur F Kavanaugh, Andrea Rubbert-Roth, et al.Immunobiology|April 5, 2005
Blockade of TNF does not alter oxygen burst and phagocytosis of human neutrophils in patients with rheumatoid arthritisPia Hartmann, Caspar Franzen, Andrea Rubbert, et al.Journal of the American Academy of Dermatology|January 5, 2002
Treatment of recalcitrant cicatricial pemphigoid with the tumor necrosis factor alpha antagonist etanerceptChristopher Sacher, Andrea Rubbert, Cathrin König, et al.Pageof 9